PNC Financial Services Group’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
IAIM
PNC Financial Services Group's ALDX Position: Q3 2026 in Review
PNC Financial Services Group sold out of Aldeyra Therapeutics (ALDX) in Q3 2026, closing a stake of 1,575 shares — an estimated $3.36K sold.
PNC Financial Services Group first reported a position in ALDX in Q2 2021 and held it in 16 quarters. The position peaked at $5.29K in Q3 2025. 40 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.
- PNC Financial Services Group reported no remaining Aldeyra Therapeutics position as of Q3 2026 after selling out during the quarter.
- PNC Financial Services Group sold 1,575 Aldeyra Therapeutics shares in Q3 2026, an estimated $3.36K.
- PNC Financial Services Group first reported a position in Aldeyra Therapeutics in Q2 2021 and held it in 16 quarters.
- PNC Financial Services Group's Aldeyra Therapeutics position peaked at $5.29K in Q3 2025.
- 40 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.